MICHELLE BUCK: Open Payments
NPI 1902682941 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 51 payments from 11 companies in 2025. Trend: 2023 $74 · 2024 $1,357 · 2025 $1,533
Food & beverage: $1,533
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $364 |
| ABBVIE INC. | 13 | $363 |
| Ardelyx, Inc. | 9 | $202 |
| Janssen Biotech, Inc. | 7 | $162 |
| Fisher & Paykel Healthcare Inc | 1 | $159 |
| Phathom Pharmaceuticals, Inc. | 9 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $91 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| VIVUS LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: REZDIFFRA, IBSRELA, TREMFYA, FISHER & PAYKEL HEALTHCARE, LINZESS, VOQUEZNA, ENTYVIO, CREON.
Industry payments across FL — which companies pay providers there.
